Fibrinolytic degradation products in urine of anticoagulated transplant patients.
A study of the level of urinary fibrinolytic split products in 14 renal transplant patients who received oral anticoagulants postoperatively revealed a tendency toward increased levels of fibrinolytic split products that were temporally related to graft rejection. The amount of fibrinolytic split products in the urine was positively related to the severity of rejection as well as to the final status of the allograft. Thus, the urinary level of fibrinolytic split products, as determined by the latex-coated particle test, can be used as an indicator of the course of warfarin-anticoagulated patients after renal allografting.
D000284:Administration, Oral; D005338:Fibrin Fibrinogen Degradation Products / Q000652:urine*; D006084:Graft Rejection; D006801:Humans; D016030:Kidney Transplantation; D014184:Transplantation, Homologous; D014859:Warfarin / Q000008:administration & dosage* / Q000627:therapeutic use
D005338:Fibrin Fibrinogen Degradation Products; D014859:Warfarin